Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therapix Biosciences Ltd ADR TRPXY

Healthcare Biotechnology
Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the Company's operation); and Pain clinic


OTCPK:TRPXY - Post by User

Therapix Biosciences Ltd ADR > TRPX today
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Fundy13on Feb 05, 2019 10:54am
46 Views
Post# 29320417

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TRPX today

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TRPX todayAbsolutly news would be great.  I wonder if they could be close to any significant update regards any of the trials going on?  $5 was the IPO price and they have made significant progress on thier drug trials since then.  
If nothing else the bump in share price will help if they need to issue any more shares to raise capital.  I do not think it comes down to that, but the higher the SP the better an option in becomes.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities